Raul Andino-Pavlovsky, PhD

Raul Andino
Global Health Sciences Faculty Affiliate

Phone: 415-502-6358
UCSF Box: 2280
Email: [email protected]
UCSF Profile

Project
 		Sponsor Location(s) Topics Start End
2013 NIH Workshop on Protein Homeostasis and Viral Infection NIH National Institute of Allergy and Infectious Disease United States Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
A Collaborative Approach to the Design of a Genetically-Stable Oral Polio Vaccine (OPV-2) Bill & Melinda Gates Foundation United States Infectious Disease, Drug and Diagnostics Development
BSL3 upgrading for Live-attenuated poliovirus testing Bill & Melinda Gates Foundation United States Infectious Disease, Immunology
Cap Independent Translation of Dengue Virus University of California Berkeley United States Zoonosis, Emerging Disease, and Drug Resistance
EV71 intra-host evolution, attenuation and vaccine development NIH National Institute of Allergy and Infectious Disease United States Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Genetic Diversity as a Determinant of Viral Adaptation and Pathogenesis NIH National Institute of Allergy and Infectious Disease United States Infectious Disease, Immunology
Genetic Diversity as a Determinant of Viral Pathogenesis and Attenuation NIH National Institute of Allergy and Infectious Disease United States Infectious Disease, Genetics, Risk Reduction and Prevention
Insect adaptive immunity NIH National Institute of Allergy and Infectious Disease United States Zoonosis, Emerging Disease, and Drug Resistance
INTERCEPT: Interfering and Co-evolving Prevention and Therapy DOD Defense Advanced Projects Research Agency United States Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Leveraging mosquito antiviral immunity to detect viral infections: Towards a scalable field-based approach for predicting arbovirus epidemics University of California Institute for Mexico and the U.S. (UC MEXUS) Mexico Zoonosis, Emerging Disease, and Drug Resistance
Linking Virus Population Genetic Structure to Infectivity and Adaptation DOD Defense Advanced Projects Research Agency United States Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance
Mechanism of enterovirus replication NIH National Institute of Allergy and Infectious Disease United States Drug and Diagnostics Development
Mechansims of poliovirus replication NIH National Institute of Allergy and Infectious Disease United States Infectious Disease, Noncommunicable and/or Chronic Disease, Genetics
Protein homeostasis mechanisms underlying enterovirus replication and evolution NIH National Institute of Allergy and Infectious Disease United States Genetics
Quasispecies and drug resistance University of California Irvine (UCI) United States Zoonosis, Emerging Disease, and Drug Resistance
RAPID: Ebola virus population structure, genetic diversity and evolution National Science Foundation (NSF) United States Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Recombinant Picornaviruses as AIDS Vaccines NIH National Institute of Allergy and Infectious Disease United States HIV/AIDS
Replication fidelity mutants as attenuated poliovirus seeds for IPV production World Health Organization (WHO) United States Drug and Diagnostics Development, Pharmacology and Drug Treatment
Replication, Pathogenesis and Evolution of RNA Viruses, Including Dengue NIH National Institute of Allergy and Infectious Disease Argentina Infectious Disease, Neglected Tropical Diseases (NTDs)
RNA Protein Interactions in Poliovirus Replication NIH National Institute of Allergy and Infectious Disease United States Risk Reduction and Prevention
RNAi as an Intercellular Antiviral Defense Mechanism NIH National Institute of Allergy and Infectious Disease United States Infectious Disease, Genetics
Selective AAK1 and GAK inhibitors for combating Dengue and other emerging viral infections Stanford University United States Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Immunology
Subcontract Work in Association with LLNL LDRD Project: COMP-08ERD036 Lawrence Livermore National Laboratory United States Zoonosis, Emerging Disease, and Drug Resistance, Drug and Diagnostics Development
Testing novel adjuvants to enhance mucosal immunity elicited by inactivated poliovirus vaccine (IPV) Global Vaccines, Inc United States Drug and Diagnostics Development, Immunology
Vaccine to Prevent HIV Infection in Pregnancy and Newborns University of California Davis United States HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health
Virus population dynamics, genetic diversity and evolution UC Lab Fees Research Program United States Zoonosis, Emerging Disease, and Drug Resistance